Immunology

The Immunology Department is responsible for teaching in Immunology at the Vetsuisse Faculty Bern and consists of four research groups concerned with the interaction of the immune system with infectious agents, especially viruses. We investigate how the immune system responds to infections and why certain viruses cause disease. To this end we use complex cell culture systems, consisting of phagocytes (scavenger cells), antigen-presenting cells (dendritic cells), epithelial cells and stem cells. Where possible, we use the resulting knowledge in the development of novel vaccines.

The diseases studied at present are foot-and-mouth disease, classical swine fever, porcine reproductive and respiratory syndrome, influenza, diseases of small ruminants caused by lentiviruses, and enzootic pneumonia in pigs. In Immunology we also have a focus on zoonoses caused by flaviviruses such as Japanese encephalitis virus and Zika virus.

News

infographie web

Novel in vitro model: an alternative method to animal testing

As part of the research on the human placenta as a target of SARS-CoV-2 (Fahmi et al, 2021), the research team of PD Dr. Marco Alves (Institute of Virology and Immunology IVI and the University of Bern) has developed an in vitro model of the human placenta. This physiological model provides a platform that paves the way for a significant replacement of in vivo approaches when evaluating pathophysiological mechanisms of virus infection during pregnancy. This new model contributes to promote the 3R Principle that aims to replace, reduce, and refine animal experimentation, and more particularly the principle of replacement.

By publishing the exact method, as developed, in the scientific journal STAR Protocols (Fahmi et al., 2022), other research teams will be able to reproduce this technique – which ultimatly may help to reduce the use of animals whenever possible.

Animal experimentation is applied to address a biological problem when no alternative method exists. The Institute of Virology and Immunology IVI is committed to the development of alternative methods.


Caption:

Method of the novel in vitro model: from placental sampling to tissue culture, thereby enabling subsequent studies of the human placenta, for example after an infection from SARS-CoV-2.


corona et palcenta

The human placenta, a target of SARS-CoV-2

What happens in the human placenta after SARS-CoV-2 infection? The IVI and CHUV research teams found that SARS-CoV-2 can infect the cells of the human placenta and that the virus can proliferate and infect neighboring placental cells.

Last modification 14.04.2022

Top of page

Contact

University of Bern
Institute of Virology and Immunology (IVI)
Länggassstrasse 122
3001 Bern

Immunology
Phone +41 (0)31 684 24 73 /
(0)58 469 93 77


Prof. Dr. A. Summerfield

Print contact

https://www.ivi.admin.ch/content/ivi/en/home/forschung/immunologie.html